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ABSTRACT 
We have previously identified the interaction between mammalian V-ATPase       
a2-subunit isoform and cytohesin-2 (CTH2) and studied molecular details of binding 
between these proteins. In particular, we found that six peptides derived from the N-
terminal cytosolic domain of a2 subunit (a2N1-402) are involved in interaction with CTH2 
(Merkulova, Bakulina, Thaker, Grüber, & Marshansky, 2010). However, the actual 3D 
binding interface was not determined in that study due to the lack of high-resolution 
structural information about a-subunits of V-ATPase. Here, using a combination of 
homology modeling and NMR analysis, we generated the structural model of complete 
a2N1-402 and uncovered the CTH2-binding interface. First, using the crystal-structure of 
the bacterial M. rubber Icyt-subunit of A-ATPase as a template (Srinivasan, Vyas, Baker, 
& Quiocho, 2011), we built a homology model of mammalian a2N1-352 fragment. Next, 
we combined it with the determined NMR structures of peptides a2N368-395 and a2N386-402 
of the C-terminal section of a2N1-402. The complete molecular model of a2N1-402 revealed 
that six CTH2 interacting peptides are clustered in the distal and proximal lobe sub-
domains of a2N1-402. Our data indicate that the proximal lobe sub-domain is the major 
interacting site with the Sec7 domain of first CTH2 protein, while the distal lobe sub-
domain of a2N1-402 interacts with the PH-domain of second CTH2. Indeed, using 
Sec7/Arf-GEF activity assay we experimentally confirmed our model. The interface 
formed by peptides a2N1-17 and a2N35-49 is involved in specific interaction with Sec7 
domain and regulation of GEF activity. These data are critical for understanding of the 
cross-talk between V-ATPase and CTH2 as well as for the rational drug design to 
regulate their function.    
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INTRODUCTION 
The V-ATPases are ubiquitous proton pumps, that use the energy of ATP to 
translocate protons from cytosol to intracellular compartments or extracellular space. V-
ATPases maintain pH homeostasis at the cellular and the whole organism level, and also 
play a critical role in cellular function via direct interaction with a variety of proteins, 
whose functions are unrelated to pH homeostasis. The direct and indirect roles of V-
ATPase were previously reviewed by us (Marshansky & Futai, 2008; Marshansky, 
Rubinstein, & Grüber, 2014) and others (Forgac, 2007; Hinton, Bond, & Forgac, 2009).  
V-ATPases are very complex multi-subunit enzymes that function as proton-
pumping rotary nano-motors (Marshansky & Futai, 2008; Marshansky, Rubinstein, & 
Grüber, 2014). Functional V-ATPases are composed of two parts: a cytoplasmic V1- and 
a transmembrane VO-sector, which may dissociate from each other in response to some 
stimuli. This dissociation results in reduced ATPase activity and a shutting down of 
proton translocation of V-ATPase, and is one of the main mechanisms of down-
regulation of V-ATPase function (Marshansky & Futai, 2008; Marshansky, Rubinstein, 
& Grüber, 2014). Each of the two sectors are composed of multiple different subunits. In 
mammalian cells eight different proteins are combined in the following stoichiometry 
A3B3C1D1E3F1G3H1 to form a V1-sector; while at least six different proteins 
a1c5c"1d1e1Ac451 form the transmembrane VO-sector. Proton pumping across the 
membrane occurs via coupling of ATP-hydrolysis with rotary-mechanism of protons 
translocation in the interface between the rotating c-ring and the stationary a-subunit of 
V-ATPase. The rotation of the c-ring is driven by ATP hydrolysis catalyzed by the 
stationary A3B3 headpiece of the V1-sector. In order to accomplish an efficient transfer of 
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ATP hydrolysis energy to c-ring rotation, the rotation of A3B3 headpiece is prevented by 
three peripheral stalks (Zhang et al., 2008). Each of these stalks is composed by a G/E 
heterodimer, which anchors the A3B3 headpiece to the membrane through either: i) direct 
binding to the N-terminal tail of a-subunit, or ii) indirectly through subunit C. In 
particular, while two of three G/E-stalks are directly bound to a-subunit, the third G/E-
stalk is bound to subunit C, which itself interacts simultaneously with a-subunit and the 
second G/E-peripheral stalk (Oot & Wilkens, 2012; Oot et al., 2017; Zhang et al., 2008). 
It is noteworthy that during the disassembly of V1-sector from VO-sector, the protein-
protein interactions between a-subunit and G/E-stalks as well as C-subunit and G/E-stalk 
are destabilized through a yet unknown molecular mechanism (Oot et al., 2017).  
In mammals there are four a-subunit isoforms, (a1, a2, a3 and a4) that contain two 
major domains: a cytosolic N-terminal domain (aN ~ 400 aa) and a membrane-integrated 
C-terminal domain (aC ~ 400 aa), containing eight transmembrane spanning helices 
(Marshansky, 2007; Toei, Toei, & Forgac, 2011). While a-subunit isoforms are highly 
homologous to one another, nevertheless they perform non-redundant functions. Initially 
we found, that the cytosolic N-terminal domain of a2-subunit (a2N1-402) directly interacts 
with cytohesin-2 (CTH2), which acts as Arf-GEF (GDP/GTP exchange factor) and 
activator of Arf-family small GTPases. Since CTH2 and Arf small GTPases are the key 
regulators of receptors signaling, vesicular trafficking and actin cytoskeleton 
rearrangement (Hurtado-Lorenzo et al., 2006; Merkulova et al., 2010), these findings 
provided new insights into the functional link between V-ATPase dependent organellar 
acidification and vesicular trafficking. Importantly, our recent study revealed that the 
other three a-subunit isoforms (a1, a3 and a4) also bind to CTH2, suggesting its 
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ubiquitous nature and cell biological significance of signaling between V-ATPase and 
CTH2 (Merkulova et al., 2011).  
Cytohesin-2 (CTH2, also known as ARNO) together with cytohesins-1, -3 and -4, 
belongs to cytohesin subfamily of Arf-GEFs, activators of Arf small GTPases (Casanova, 
2007). Cytohesins are highly homologous proteins composed of four distinct structural 
domains: i) an N-terminal coiled-coil domain; ii) a central Sec7-domain; iii) a pleckstrin 
homology (PH) domain; and iv) a C-terminal polybasic domain. In our previous study we 
addressed the molecular details of binding between CTH2 and a2N1-402 (Merkulova et al., 
2010) and uncovered very complex interactions between these proteins. We found 
multiple binding sites within the Sec7 domain of CTH2 as the strongest interaction sites 
with a-subunit of V-ATPase (Merkulova et al., 2010). Moreover, homology modeling of 
CTH2 performed in our study also suggested the multisite binding and complex character 
of interactions between these two proteins (Merkulova et al., 2010). Indeed, pull-down 
experiments using synthetic peptides demonstrated that six a2N1-402 specific peptides 
a2N1-17, a2N35-49, a2N198-214, a2N215-230, a2N313-331 and a2N386-402 are involved in the 
interaction with full-length CTH2 (Merkulova et al., 2010). Intriguingly, these peptide 
motifs were not clustered but instead randomly distributed throughout the sequence of 
a2N1-402 of V-ATPase (Merkulova et al., 2010). Additional pull-down and surface 
plasmon resonance experiments with purified domains of CTH2 revealed that peptide 
a2N1-17 interacted specifically and strongly with Sec7 domain, while peptide a2N198-214 
interacted with PH domain (Merkulova et al., 2010). This data suggested that the epitope 
formed by a2N1-17 is most likely involved in interaction with Sec7 domain, while the 
epitope formed by a2N198-214 is probably part of a different binding site, involving the PH-
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domain of CTH2. However, this hypothesis could not be verified due to the lack of 
structural features of the a2N1-402 subunit of V-ATPase.  
Previously, a high-resolution crystal structure of cytosolic N-terminus of I-subunit 
(Icyt) of Meiothermus ruber A-ATP synthase was solved (Srinivasan et al., 2011). This 
protein is homologous to yeast Vph1 and mammalian a-subunit isoforms of V-ATPase. 
Overall, Icyt is composed of a curved long central α-helical bundle capped on both ends 
by two lobes with similar α/β architecture that shows remarkable structural similarity 
with yeast C-subunit of V-ATPase (Srinivasan et al., 2011). The crystal structure of Icyt 
also fits well into the corresponding place in an electron microscopy density map of intact 
A-ATP synthase from Thermus thermophilus bacteria (Lau & Rubinstein, 2012; 
Srinivasan et al., 2011). Importantly, extensive analysis of the multiple alignments of all 
currently known a-subunits of V-ATPase demonstrated the evolutionarily conserved 
character of these proteins and their structures. This in turn opens the possibility to 
generate homology models of N-terminal cytosolic domains of a-subunit isoforms from 
other species including mammals. 
 Here, we used the crystal structure of Icyt from Meiothermus ruber to build a 
homology model of mouse a2-subunit (a2N1-352) of V-ATPase. Moreover, we also solved 
the NMR structures of two synthetic overlapping peptides derived from a2N339-402 in 
order to determine the structural features of this unknown part of the protein and to build 
a structural model of the entire a2N1-402 cytosolic tail. Using this model, we determined 
the distribution of CTH2 interacting epitopes clustered in two spatially separate binding 
regions on 3D structural model of a2N1-402. We also outlined and analyzed a G/E-stalks 
binding interfaces on a2N1-402 based on previously published data from the Forgac 
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laboratory (Qi & Forgac, 2008). Our data suggest the complex interaction between a2-
subunit V-ATPase and CTH2 that may modulate binding between a2-subunit and G/E-
subunits of the peripheral stalks. We propose this interplay between these interactions as 
a molecular mechanism of cross-talk between trans-membrane V-ATPase complex, 
cytosolic CTH2 and Arf small GTPases. 
 
RESULTS 
The structure of Meiothermus ruber Icyt subunit as a template for mouse 
a2N1-352 homology model. The first high-resolution structure of A-ATP synthase M. 
ruber Icyt has been solved previously (Srinivasan et al., 2011), which opened the 
possibility to generate homology models of cytosolic N-terminal domains of a-subunits 
from other species. We performed multiple amino acid sequence alignment of a-subunit 
homologues from various species in order to assess a general overview of a-subunit 
evolution. This analysis revealed that high level conservation of amino acid sequences of 
cytosolic N-terminal tail of a-subunits from different species is not required for 
preservation of the overall secondary and tertiary structures. Thus, we concluded that Icyt 
could be used as a template to build a reliable model of 3D structure of the mouse a2N 
protein.  
 
The homology model of a2N1-352 structure. The homology modeling of a2N1-352 
was performed using the crystal structure of Icyt from M. ruber (PDB ID: 2RRK) as a 
template as described in Methods. The crystal structure of M. rubber Icyt represents the 
amino acids 1-301 (Icyt_1-301), whereby the C-terminal 50 amino acids of Icyt including the 
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residues 302-351 (Icyt_302-351) remained unresolved (Srinivasan et al., 2011). Since Icyt_1-301 
is an independently folded structural unit, it most likely represents the separate domain of 
M. ruber I subunit. In the mouse a2N sequence this separate domain corresponds to a2N1-
352 region (Figure 1). The homology-modeled structure of mouse a2N1-352 adopts the 
same overall shape of a barbell as its Icyt template and contains the same three major 
structural elements (Figure 2a-c, Supplementary Movie S1). The domain composition of 
a2N1-402 is shown in Figure 2a and the color and amino acids composition of the 
structural elements also correspond to the ribbon structures shown in Figure 2b-c, 
respectively. The proximal lobe (PL) with the mixed α/β architecture is formed by two 
distinct amino acid regions 1-42 aa (PL, red) and 322-352 aa (PL, red). The distal lobe 
(DL) with the similar mixed architecture is formed by a single continuous amino acid 
stretch 173-244 aa (DL, blue). The central bar domain (BD) is also formed by two distinct 
amino acid regions 43-172 aa (BD, green) and 245-321 aa (BD, green) which contains 
two anti-parallel rows of long α-helices, that link two lobes together (Figures 1 and 2b,c). 
The proximal lobe consists of 4 anti-parallel β-strands (Figure 1, strands 1, 2, 6 and 7) 
and 2 α-helices (Figure 1, helices I and XI) that fold into two-layer α/β sandwich. The 
strands-2 and 7 are not visible in the model since these regions assigned by PyMOL as 
loops, Swiss-PDB Viewer (Guex, Peitsch, & Schwede, 2009) assigns β-strands for these 
regions, while PsiPred predicts β-strand for strand-2 (Figure 1, in blue). Thus we suggest 
that this is not a significant difference between the model and the template. The distal 
lobe is composed of 3 antiparallel β-strands (Figure 1, strands 3, 4 and 5) and 2 α-helices 
(Figure 1, helices VI and VII) that fold into similar two-layer α/β sandwich. The ‘extra’ 
51 residues of a2N are predominantly located in very N-terminus (additional 9 aa) and 
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contribute to the formation of the longer loops between α-helices II and III, α-helix V 
and β-strand 3, and between β-strands 4 and 5 (Figures 1 and 2). Thus the overall 
structure of a2N1-352 model is very similar to the crystal structure of Icyt.  
 
The NMR structure of a2N353-402 region. The cytosolic N-terminal tail of mouse 
a2-subunit (a2N1-402) has been predicted to span 1-402aa (Figure 1) (Merkulova et al., 
2010). Thus the homology model of a2N1-352 is not a complete part of the cytosolic N-
terminal tail, since the last 50 aa (a2N353-402) could not been modeled using Icyt_1-301 as a 
template. Since, this part of a2N1-402 is connecting the rest of the tail to its predicted first 
transmembrane domain, we called this part of the protein the stem domain (SD) (Figure 
2a and 3a, 353-402 aa in white). In addition, the region 386-402 of mouse V-ATPase 
subunit a2-isoform has been shown to be essential for binding to CTH2 Arf GEF small 
GTPase (Merkulova et al., 2010). Here were synthesized the overlapping peptides a2N339-
395 and a2N386-402, which were derived from the a2N339-402 region (Figure 3a, in cyan). 
The solution structure of entire a2N386-402 (in cyan) and part of a2N339-395 (in cyan), 
shown as a2N368-395 (in gray), were solved by NMR spectroscopy. Amino acids of the 
peptides were sequentially assigned using both NOESY and TOCSY data. 2D TOCSY 
and 2D NOESY raw data was processed using in-built Topspin software (Bruker). Figure 
4a-b show the assigned NH region of the 2D NOESY spectrum of a2N339-395 and a2N386-
402 (Figure 3a, in cyan). Primary sequence amino acid marking was followed by the 
assignment of cross peaks by overlaying 2D TOCSY and 2D NOESY spectra (Figure 4a-
b). The secondary structure elements of a2N339-395 were analyzed based on 1Hα chemical 
shifts with respect to the random coil values. In case of a2N339-395 the data indicate an α-
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helical formation between the amino acids N373 to Y386 (Figure 4c). Identified cross peaks 
in the HN-HN region are shown in Figure 4e, indicating α-helical features of a2N339-395. 
HN–HN, Hα–HN(i, i+3), Hα–HN(i, i+4), and Hα–Hβ (i, i+3) connectivities were plotted 
from the assigned NOESY spectrum (Figure 4e). Hα–HN(i, i+3), indicating α-helical 
formation between the residues G378 to Y387, whereby Hα–HN(i, i+2) between T372 and 
F375 indicates a potential α-helical turn. Data from assigned 2D NOESY spectra, torsion 
angle calculated from HA values by TALOS software and primary amino acid sequence 
were used as input for the automated structure calculation by Cyana 3.0 package 
(Herrmann, Güntert, & Wüthrich, 2002). Since the 2D NOESY assignment of a2N339-395 
reveals an unstructured N-terminal part, the calculation was performed only for the C-
terminal region with the residues 368 to 395, called a2N368-395 (Figure 3a, in grey). Out of 
100 generated structures the 20 lowest energy structures were taken for further analysis. 
In total an ensemble of 20 calculated structures resulted in an overall mean root square 
deviation (RMSD) of 0.297 Å for the residues 378-387 (Figure 3b). All the structures of 
a2N368-395 have energies lower than -100 kcal mol-1, no NOE violations greater than 0.3 Å 
and no dihedral violations greater than 5º. The statistics for 20 structures are shown in 
Figure 3b. The structure of a2N368-395 shows a total length of 43.05 Å and forms a flexible 
N-terminal region from residues 368-371 with a helix extending from amino acids 372-
375, followed by a short loop from 376-378 and a second helix between the residues 379-
387 (Figure 5a,b), while the remaining C-terminal region is flexible. Molecular surface 
electrostatic potential of a2N368-395 reveals an amphiphilic surface (Figure 5c,d). At one 
side of the peptide, residues E377, D384 and E393 are forming a negative charged surface 
(Figure 5c). The opposite side reflects an amphiphilic surface potential, formed by the 
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charged residues at the N- and C-termini as well as the hydrophobic residues F375, F379, 
I382, V383, A385, Y386 V388, and Y391 (Figure 5d). 
 
In parallel, the secondary structure elements of a2N386-402 showed α-helical 
formation between the amino acids P396 to I402 (Figure 6a,b). HN–HN, Hα–HN(i, i+3), 
Hα–HN(i, i+4), and Hα–Hβ (i, i+3) connectivities were plotted from the assigned 
NOESY spectrum (Figure 4f) and reflecting α-helical formation in the C-terminus. In 
total an ensemble of 20 calculated structures resulted in an overall mean root square 
deviation (RMSD) of 0.68 Å (Figure 3b). All these structures have energies lower than -
100 kcal mol-1, no NOE violations greater than 0.3 Å and no dihedral violations greater 
than 5º (Figure 3b). The a2N386-402 peptide contains an unstructured N-terminal region 
formed by the amino acid residues 386 to 395 and a C-terminal α-helical region from 
residues 396 to 402 (Figure 6b). Since a2N386-402 in the intact protein is predicted to be 
locate on the border of the cytoplasmic and membrane-embedded parts of a2-subunit 
(Merkulova et al., 2010), we propose that this C-terminal helix of a2N386-402 corresponds 
in fact to the beginning of the first transmembrane helix of the a2-subunit of V-ATPase. 
 
The complete model of a2N1-402. In order to build a 3D model of the entire    
a2N1-402 region, the homology model of a2N1-352 was combined with NMR structures of 
the two peptides a2N368-395 (Figure 5) and a2N386-402 (Figure 6) as described in Methods 
(Figure 7, Supplementary Movie S2). In comparison with the a2N1-352 structural model, 
three additional α-helices can be assigned in the a2N1-402 model (Figure 1, helices XII, 
XIII, and XIV), which are connected by unstructured linkers (Figure 7a,b,d). According 
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to a2N1-402 model only α-helix XIII lays close to α-helix I of a2N1-352 region. Overall, 
a2N353-402 region represents an appendage joined to the a2N1-352 structural core through a 
flexible linker formed by amino acids 353-371 between β-strand 7 and α-helix XII 
(Figure 1). This appendage will most likely contributes to the formation of the short stem 
domain (SD), which connects the cytosolic and membrane-embedded parts in intact full-
length a-subunit of V-ATPase as observed on electron microscopy images (Lau & 
Rubinstein, 2010, 2012). 
 
The calculated a2N1-402 molecular model can be fitted well into the density of the 
barbell-shaped collar of the 23 Å resolution EM map of the related P. furiosus A-ATP 
synthase (EMD-1542)(Vonck, Pisa, Morgner, Brutschy, & Müller, 2009) with a 
correlation coefficient being 0.8702, as calculated using the Chimera program [30] and as 
shown Figure 8a-b. The fit takes into consideration that the regions a2N140-173 and a2N206-
222, which are segments of the eukaryotic V-ATPase subunit and absent in M. ruber A-
ATP synthase Icyt template, are presented as unstructured regions in the final a2N1-402 
model (Figure 7a,c,d). In addition, the structures of the subunits E and H of the T. 
thermophilus and Pyrococcus horikoshii OT3 A-ATP synthase are well accommodated 
by the density of the straight and bent peripheral stalk with a correlation of 0.7827 and 
0.7704, respectively, as described most recently [32]. The structure of the H+-
translocating c-ring (Murata, Yamato, Kakinuma, Leslie, & Walker, 2005; Vonck et al., 
2009) was fitted with a correlation coefficient being 0.8601. 
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The structural model and features of CTH2 binding interface on a2-subunit 
of V-ATPase. While six CTH2 interacting peptides are evenly distributed in amino acid 
sequence of a2N1-402 (Merkulova et al., 2010), our complete a2N1-402 model revealed that 
epitopes formed by these peptides are forming just two spatially distinct binding sites for 
two molecules of CTH2 (Figure 7a-d). The CTH2 interacting peptides a2N1-17, a2N35-49, 
a2N313-331 and a2N386-402 are clustered together in the proximal lobe (PL) into the first 
binding site (Figure 7a,d left and Figure 7b). Three of these peptides a2N1-17, a2N35-49 and 
a2N313-331 form a continuous surface from the β-strands 1, 2 and 6, and the adjacent loops 
(Figure 1 and Figure 7a,b,d), while a2N386-402 peptide is separate and forms an additional 
binding surface (Figures 1, 5a and 5b Figure 7a,d left and Figure 7b). The second CTH2 
binding site is composed by a2N198-214 and a2N215-230 peptides which form a continuous 
surface from the β-strands 4 and 5, and the loop between them in the distal lobe (DL) of 
a2N1-402 (Figure 1 and Figures 7a,d right and c). Thus, both binding sites have a very 
similar predominantly β-sheet architecture, except for the presence of an additional 
unique α-helical region XIV of a2N386-402 peptide in the proximal lobe binding interface. 
Importantly, according to a2N1-402 model, both sites are not buried inside the protein 
molecule but are exposed and readily accessible to binding to CTH2. 
 
Mapping of the G/E peripheral stalk interaction sites on structural model of 
a2N1-402. Previously, Forgac and co-workers performed extensive site-specific cross-
linking experiments with the N-terminal domain of yeast Vph1p, a homolog of 
mammalian V-ATPase a-subunit (Qi & Forgac, 2008). Following five amino acid 
residues in Vph1 G181, S266, A347, A351 and Q369 that are located in proximity or 
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interacting with G/E peripheral stalks of V-ATPase were identified (Qi & Forgac, 2008). 
We applied this data to a2N1-402 structural model, in order to reconstitute the G/E-binding 
interface on the mouse a2-subunit of V-ATPase. According to multiple sequence 
alignment, G181, S266, A347, A351, and Q369 amino acids of Vph1p correspond to G170, T255, 
P336, R340 and N358 in mouse a2N sequence (Figure 1). In the structural model of a2N1-402 
the G170 residue is located in the unstructured loop, connecting α-helix V of the central 
region and first β-strand 3 of the distal lobe (Figure 1 and 7d, right). The residue of T255 
is in close proximity and a forming part of the short predicted α-helix connecting 
unstructured region behind the last α-helix VII of the distal lobe and α-helix VIII of the 
central bar region (Figure 1 and 7d, right). Thus, both amino acids G170 and T255 come 
close together in the structural model and most likely are forming one G/E-binding 
interface in the distal lobe of a2N1-402 (Figure 7d, right). The next two of five residues 
P336 and R340 are located in the proximal lobe of a2N1-402 forming a single continuous 
interface in the same α-helix XI (Figure 1 and 7d, left). In close proximity to this surface 
is residue N358, which is located in the middle of the unstructured linker that connects 
core and appendage domains of a2N1-402. Thus, all three amino acids P336, R340 and N358 
come close together in the structural model and most likely are forming another G/E-
binding interface on the proximal lobe of a2N1-402 (Figure 7d, left).  
 
Identification of V-ATPase interface involved in binding with CTH2 and 
modulation of its GEF activity. According to our studies, two V-ATPase derived 
peptides a2N1-17 and a2N35-49 are forming a specific interaction interface on proximal lobe 
(PLSD) sub-domain of a2N that is involved in interaction with Sec7 domain of CTH2 
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(Figure 8a, shown by gray rectangle). To confirm our model, we therefore performed an 
additional GEF activity experiments using recombinant Sec7 CTH2 domain and a2N V-
ATPase derived synthetic peptides (Bio-a2N1-17 -TAT; Bio-a2N18-34 -TAT; Bio-a2N35-49 -
TAT; Bio-a2N75-91 -TAT and Bio-a2N313-331-TAT)(Figure 8g). Experimental testing of 
our model demonstrated a potent inhibition of Sec7/Arf1-GEF activity by both           
Bio-a2N1-17-TAT (IC50 = 1.5 µM) (Figure 8b) and Bio-a2N35-49-TAT (IC50 = 0.9 
µM)(Figure 8c), peptides forming an interface highlighted in gray rectangle on Figure 8a. 
However, peptides of a2N V-ATPase that are not involved in formation of a binding-
competent interface: Bio-a2N18-34-TAT (Figure 8d), Bio-a2N75-91-TAT(Figure 8e), Bio-
a2N313-331-TAT (Figure 8f), are not able to modulate the function of CTH2 Sec7 domain 
in a Sec7/Arf1-GEF activity assay. These data indicate that the interface formed by a2N1-
17 and a2N35-49 of V-ATPase  (Figure 8a) is specifically involved in the interaction with 
Sec7 domain and regulation of enzymatic GEF activity of CTH2. 
 
DISCUSSION 
In this study we generated the structural model of a2N1-402 and uncovered two 
binding interfaces for Arf GEF CTH2. The complete molecular model of a2N1-402 
revealed that all CTH2 interacting peptides are located in distinct regions of the proximal 
lobe (PL) and distal lobe (DL) of a2N1-402 and there are no interacting epitopes in the 
central bar domain (BD) of the protein (Figure 7). The average distance between two 
CTH2 binding sites on a2N1-402 was estimated as ~ 73 Å. The first CTH2 binding 
interface located in PL is formed in part by the externally exposed a2N1-17, and a2N35-49 
peptides (Figure 7a,b, Figure 9). According to our previous studies these two peptides are 
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specifically interacting with Sec7 domain of cytohesin-2 (Merkulova et al., 2010). 
Therefore, here we conclude that this first PL located binding interface is the major 
CTH2 binding site, which is involved in interaction with catalytic Sec7 domain of first 
CTH2. Two other peptides a2N313-331 and a2N386-402 are also located in this region. 
However, these peptides do not interact with Sec7 domain, while they are interacting 
with full-length CTH2 in pull-down experiments (Merkulova et al., 2010). We conclude, 
that epitopes formed by these peptides are most likely involved in the interaction with 
regulatory elements of CTH2 such as Sec7/PH-linker, PH- and/or PB-domains, which are 
located in the close proximity to the Sec7 domain (Merkulova et al., 2010). Finally, based 
on our previous data showing low affinity interaction of peptide a2N198-214 with purified 
PH-domain, we hypothesized that the second DL located epitope should be involved in 
interaction with only regulatory PH-domain of second CTH2 (Figure 7a,c, Figure 9). 
 
What would be the molecular role and cell biological functional significance of 
such a complex and differential interaction between a2-subunit of V-ATPase and two 
molecules of CTH2? Previously, we reported that interaction between a2-subunit and 
CTH2 is depending upon V-ATPase driven acidification of the endosomal lumen which 
suggests, that V-ATPase itself could function as pH-sensing receptor (Hurtado-Lorenzo 
et al., 2006). Thus, we indeed identified V-ATPase as a novel signaling receptor that on 
one hand, is sensing the acidification status of endosomal lumen, and on the other hand, 
could transmit this information across the membrane and modulate activity of the Arf-
GEF CTH2 and cognate Arf small GTPases. The Arf family of small GTPases (Arf1 - 
Arf6) belongs to the Ras-superfamily small GTPases that function as “molecular 
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switches” and regulate multiple cellular functions. CTH2 as an Arf-GEF is a regulatory 
protein, whose main function is the activation of Arf small GTPases and thus regulating 
multiple down-stream effectors. Previously, we suggest that cytohesin/Arf’s might 
function as “molecular on/off switches” for self-regulation of the V-ATPase function 
(Marshansky & Futai, 2008). In particular we proposed that cross-talk and signaling 
between a2-subunit and CTH2 might be involved in self-regulated acidification-
dependent disassembly of V-ATPase and shutting down of its function as a proton-
pumping nano-motor (Marshansky & Futai, 2008). Here using structural insights from 
a2N1-402 model we test this hypothesis.  
 
Insights from structural model of a2N1-402: Regulatory role of CTH2 in 
modulation of V-ATPase function. Importantly, our structural model of a2N1-402 and 
identification of its interacting interfaces with both CTH2 and G/E-stalks provide basis 
for analysis of the potential molecular mechanism of self-regulation of V-ATPase 
function. Cryo-electron microscopy study of the intact holo-complex of V-ATPase 
demonstrates that a-subunit and C-subunit of V-ATPase are oriented parallel to the 
membrane surface forming so called “colar” separating V1- and VO-sectors of V-ATPase 
(Lau & Rubinstein, 2010, 2012). Thus, one of the major structural roles of the a-subunit 
as part of V-ATPase complex is to hold together V1- and VO-sectors during its rotational 
catalysis, in particular via its interaction with G/E peripheral stalks (Forgac, 2007). This 
model is supported by various cross-linking, two-hybrid, co-immunoprecipitation and 
electron microscopy experiments showing that cytosolic N-terminal tail of a-subunit 
directly interacts with A-, G-, E-, H- and C-subunits of V1- sector of V-ATPase (Forgac, 
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2007). If the a-subunit is involved in such multiple interaction with other subunits of V1-
sector of V-ATPase, the question arises of how and when subunit a interacts with CTH2? 
One possibility is that CTH2 interacts with VO-sector only after disassembly of the 
V1/VO-complex complex when a-subunit becomes more exposed for its binding. In this 
scenario CTH2 may share the same binding interfaces with other subunits of V1-sector, 
such as G/E, competing for their binding with a-subunit, and thus, preventing the 
assembly of yet unassembled V-ATPase or the re-assembly of previously disassembled 
V-ATPase. In another scenario the interaction between CTH2 and a-subunit may take 
place in the intact V1VO-ATPase. In this case the G/E peripheral stalk subunits of V1-
sector and CTH2 would have different and not overlapping binding interfaces on a2N1-
402, which however, might trigger structural rearrangements upon CTH2 binding resulting 
in the disassembly of V1/VO-complex.  
 
The structural model of a2N1-402 and identification of its interacting interfaces 
with both CTH2 and G/E peripheral stalks helps to evaluate these possibilities. Our data 
demonstrated that there are two non-identical and non-overlapping sites on a2N1-402 for 
both G/E stalks and CTH2. In case of G/E stalks, each of these two sites directly bind two 
out of three G/E peripheral stalks in intact V-ATPase complex (Zhang et al., 2008). The 
first G/E-binding interface is located in proximal lobe and is formed by α-helix XI and 
unstructured linker that connects core and appendage domains of a2N1-402 (Figure 7d, left, 
PL). The second G/E-binding interface is located in distal lobe and is formed by the 
unstructured loop and the short predicted α-helix, preceding α-helix VII (Figure 7d, 
right, DL). Similarly, CTH2 has also got two distinct and non-overlapping binding sites. 
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While the CTH2 binding interface is in close proximity to the G/E interaction sites, they 
are not, however, identical since the G/E- and CTH2 binding motifs form separate non-
overlapping interaction surfaces (Figure 7d). This non-overlapping character of CTH2 
and G/E-binding surfaces identified in a2N1-402 model suggests that CTH2 might be 
recruited and interacts with intact V1/VO-complex. This possibility was recently 
confirmed in our experiments with intact S. cerevisiae V-ATPase and a truncated form of 
CTH2 (Hosokawa et al., 2013). Thus our data indicate that CTH2 does not compete with 
G/E subunits for binding to a2-subunit of V-ATPase. However, its binding may 
compromise the stability of interaction between the a2-subunit and the G/E peripheral 
stalks. Thus, according to this model we conclude, that the acidification-dependent 
recruitment of CTH2 to V-ATPase previously uncovered in our studies (Hurtado-Lorenzo 
et al., 2006) is most likely involved in regulating disassembly of intact V1/VO-complex 
rather than being involved in prevention of assembly of V-ATPase (Figure 9a). We have 
also recently proposed an alternative mechanism of V-ATPase regulation by CTH2 (Dip, 
Saw, Roessle, Marshansky, & Grüber, 2012). According to this model, binding of the 
CTH2 to the proximal lobe of the N-terminal domain of Vph1 (yeast homolog of a-
subunit) of V-ATPase could affect ion-translocation in the interface of the c-ring and the 
C-terminal membrane-embedded domain of a-subunit (Figure 9b). 
 
In summary, combining of homology modeling and NMR structural analysis give 
rise to the structural model of a2N1-402, which allow to uncover the molecular features of 
CTH2-binding interfaces on V-ATPase. Our model reveals the existence of two CTH2 
binding sites located on the distal and proximal lobes of a2N1-402. We also determined 
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that while Sec7-domain is a major interaction site on the proximal lobe of a2N1-402, its 
distal lobe most likely interacts with only the PH-domain of CTH2. The further analysis 
revealed, that these two CTH2 binding sites are in a close proximity to two G/E-binding 
sites on subunit a. Thus, we hypothesize, that binding of CTH2 to the V-ATPase complex 
may destabilize binding of both G/E peripheral stalks to the a-subunit, triggering 
disassembly of V-ATPase into a V1 and VO-complex (Figure 9a) and/or shutting down 
proton pumping activity of the V-ATPase nano-motor (Figure 9b). However, this 
hypothesis is only the first step to uncover the molecular details of the interaction, 
interplay and signaling between V-ATPase, CTH2 and Arf family small GTPases. While 
recently performed multi-sequence alignment analysis of interaction sites between V-
ATPase and CTH2 have uncovered the evolutionary conservation of their binding-
mechanism (unpublished data), these models are awaiting experimental testing and 
confirmation using alternative molecular and cell biological approaches. Our final goal in 
uncovering these interactions is a structure-based design of small molecules that would 
specifically interfere with interactions between V-ATPase and CTH2. These small 
molecules can be used as drugs to modulate: i) either function of V-ATPase; or ii) 
signaling and function of CTH2 and Arf family small GTPases in variety of diseases, 
since both V-ATPase and CTH2/Arf6 small GTPases are emerging as an important drug 
targets (Marshansky, Rubinstein, & Grüber, 2014).  
In particular, one of the subunits of eukaryotic V-ATPase was identified as 
(pro)renin receptor (PRR) playing a central role in the activation of the local renin-
angiotensin system (RAS)(Danser, 2009; Ichihara & Kinouchi, 2011; Marshansky et al., 
2014).  Previously, it was uncovered that over-activation of PRR is strongly associated 
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with cardiovascular hypertensive and kidney diseases (Danser & Deinum, 2005; Ichihara, 
Kaneshiro, Takemitsu, Sakoda, & Itoh, 2007). Thus, future studies in this area could lead 
to the development of novel therapeutic approaches for the treatment of hypertension and 
its complications (Li, Zhang, & Zhuo, 2017; Sun, Danser, & Lu, 2017). Moreover, the V-
ATPase is also emerging as an important drug target, able to control signaling and 
trafficking of another receptors such as EGFR/ErbB, Fz/LRP6 and Notch, and thus useful 
for treatment of lung cancers among others (Lu et al., 2013; Marshansky et al., 2014; 
McGuire, Cotter, Stransky, & Forgac, 2016; Stransky, Cotter, & Forgac, 2016).  
On the other hand, cytohesin2 (CTH2) and Arf6 small GTPase have emerged as 
critical regulators of Slit2–Robo4–paxillin–GIT1 network which controls vascular 
stability and leak (Jones et al., 2009; London & Li, 2011). Inhibition of CTH2/Arf6 
function can significantly reduce vascular permeability, which identified them as a new 
therapeutic target for ameliorating diseases involving the vascular system. In particular, 
cardiovascular hypertension and acute lung injury (ALI)/adult respiratory distress 
syndrome (ARDS), diseases in which inflammation, cytokine storm and vascular leak are 
present (Jones et al., 2009; London & Li, 2011), may be effectively treated by drugs 
targeting these proteins. 
 
METHODS 
Bioinformatics analysis and a2N1-402 homology modeling. 
The prediction of the secondary structure of a2N1-402 was performed using PsiPred 
on-line server (http://bioinf.cs.ucl.ac.uk/PSIPRED/)(Buchan et al., 2010). The model of 
1-352 part of a2 was built by homology modeling with MODELLER software (Eswar et 
al., 2006). The crystal structure of recently solved cytoplasmic N-terminal domain of 
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subunit I, homolog of subunit a, of V-ATPase (PDB ID 2RRK) was used as a template 
for homology modeling (Srinivasan et al., 2011). The alignment for homology modeling 
is based on profile-profile alignment of a2 homologs alignment and subunit I homologs 
alignment. Also subunit I secondary structure and a2 PSIPRED predicted secondary 
structure were taken into account (Buchan et al., 2010). For joining the homology a2N1-
352 model and the NMR peptide structures, Autodock Vina docking program was used to 
build several complexes of a2N1-352 model and a2N378-387  fragment from NMR structure 
of a2N368-395 peptide (Trott & Olson, 2010).  
Then the NMR structure of the entire a2N368-395 peptide was fitted to these complexes 
and the complex was selected where the peptide did not intersect with the protein. The 
final model was builT by Modeller based on two templates: 1) the aforementioned 
complex of a2N1-352 and a2N368-395 peptide, and 2) NMR structure of a2N386-402 peptide. 
Lastly, in the final model dihedral angles of Glu393 were manually changed for better fit 
into the cryo-EM map segment corresponding to I subunit of the T. thermophilus V-
ATPase (Lau & Rubinstein, 2012) and fitting itself is described below separately. 
 Also I-TASSER software was used for building a2N1-402 model (Roy, Kucukural, 
& Zhang, 2010). We made some modification to I-TASSER, which allow to set several 
preferred templates, and used 2RRK and NMR peptides structures as templates. a2N1-352 
parts of I-TASSER models were very similar to corresponded parts of the Modeller 
homology model. But all I-TASSER models were not in good agreement with Cryo-EM 
map and our knowledge about a2N structure, with 353-402 part interacting with BD 
domain (data not shown). The possible reason is following: I-TASSER is optimized for 
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globular proteins and can not take into account proximity of membrane which influences 
a2N1-402 structure. 
 
NMR data collection, processing and peptide structure determination. 
NMR spectra of a2N339-395 and a2N386-402, respectively, were collected at 
temperature ranging from 288 K to 298 K on Avance cryo-probed 600 or 700 MHz 
instruments (Bruker, Billerica, MA). All NMR data were processed using Bruker Avance 
spectrometer in-built software Topspin program. To elucidate the structure of a2N339-395 
and a2N386-402, data were collected on Bruker Avance at 600 MHz or 700 MHz. Pulse 
calibrations and other parameter including temperature, buffer and peptide concentration 
were optimized before making final measurements. 10 % D2O was used to lock the NMR 
signal in each experiment. The two dimensional (2D) 1H NMR spectra including total 
correlation spectroscopy (TOCSY) and nuclear overhauser enhancement spectroscopy 
(NOESY) were obtained at the temperature of 298 K. 2D experiments with TOCSY were 
performed with mixing time of 60 to 80 ms, whereby NOESY used 200 to 300 ms mixing 
time. Baseline corrections were applied wherever necessary. The proton chemical shift 
was referenced to the methyl signal of DSS (2, 2-dimethyl-2-silapentane-5-sulphonate 
[Cambridge Isotope Laboratories]), an external standard reference to 0 ppm. Peak-
assignment and data analysis of the Fourier transformed spectra were performed with 
SPARKY 3.1 program (Kneller & Goddard, 1997). Assignments were carried out 
according to the classical procedure including spin system identification and sequential 
assignment (Wüthrich, 1986). Inter proton distance were obtained from the NOESY 
spectra. NOESY peaks were categorized as strong, medium and weak based on the signal 
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intensity and were translated into distance constraints as 3.0 Å, 4.0 Å and 5.0 Å, 
respectively. Dihedral angle restraints were calculated from the spectra assigned chemical 
shift using torsion angle likelihood obtained from shift and sequence similarity (TALOS) 
(Cornilescu, Delaglio, & Bax, 1999). The secondary structures were predicted using the 
chemical shift index (CSI) and NOE pattern. Structure calculations were performed by 
using Cyana program which uses simulated annealing with molecular dynamics in torsion 
angle space (Güntert, Mumenthaler, & Wüthrich, 1997). Final Cyana ensemble structures 
were visualized by Pymol (DeLano, 2002).  
 
Reagents, Peptides Synthesis, Labeling, and Purification  
If not otherwise specified, all reagents were purchased from Sigma. Peptide 
synthesis resins and Fmoc-protected amino acids were purchased from EMD Chemicals. 
All peptides were synthesized, purified by HPLC, and analyzed by mass spectrometry as 
previously described (Hosokawa et al., 2013). The following a2N-derived peptides were 
synthesized: 
a2N339-395 
 (RRALEEGSRESGATIPSFMNIIPTKETPPTRIRTNKFTEGFQNIVDAYGVGSYREV)   
a2N386-402 
(YGVGSYREVNPALFTII) 












Recombinant proteins and GEF Activity Assay  
In these experiments, we used radiolabel-based assay to determine the GDP/GTP 
exchange activity of Sec7 domain and cytohesin-2 (CTH2). This assay allows the steady-
state enzymatic GEF activity analysis of Sec7 domain and cytohesin-2 (CTH2) with 
delta17-Arf1 in the presence of PIP2-containing liposomes. Preparation of recombinant 
proteins (CTH2, Sec7, delta17-Arf1) and experimental procedures of GEF activity assay 
were previously described (Hosokawa et al., 2013).  
 
FIGURE LEGENDS 
Figure 1. Amino acid sequence alignment of the cytosolic N-terminal regions 
from bacterial M. ruber subunit I, fungal S. cerevisiae Vph1p and mammalian M. 
musculus a2-subunit isoform. The alignment is performed as described in Methods. 
Identical residues are highlighted in red. The secondary structures of α-helices (α) and β-
strands (β) on top in black are from bacterial Icyt crystal structure. The secondary 
structures of mouse a2N1-402, predicted by PsiPred, or assigned by PyMol for Modeller 
and I-Tasser models are on the bottom in blue. These secondary structures look similar to 
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each other and to the secondary structure of Icyt, however while two long continuous α-
helices are present in a2N model, the corresponding two regions in Icyt each contains 
three α-helices (III, IV, V and VIII, IX, X) disrupted by kinks. The α-helices in the very 
bottom row are from NMR solution structures of peptides a2N368-395 and a2N386-402. Five 
residues of Vph1 including G181, S266, A347, A351, and Q369 (Qi & Forgac, 2008) and the 
corresponding mouse residues G170, T255, P336, R340 and N358 are highlighted in green. 
Cytohesin-2 interacting peptides a2N1-17, a2N35-49, a2N198-214, a2N215-230, a2N313-331 and 
a2N386-402 are underlined on a2N1-402 sequence, while discontinuous proximal Icyt_1-33 and 
Icyt_274-301 and continuous Icyt_135-196 distal lobe regions are underlined on Icyt sequence. 
They also are shown as separate stack of amino acid sequences. Numbers below a2-
subunit lines are from a2N amino acid sequence. The very bottom stack of amino acid 
sequences (a2N353-402 in a2N) is an appendage region of these proteins with previously 
unknown structure. 
 
Figure 2. Structural homology model of a2N1-352. a) Schematic representation 
of structural domains of a2N1-402. These structures are indicated as follows: i) proximal 
lobe (PL) formed by 1-42 aa and by 322-352 aa in red; ii) bar domain (BD) formed by 
43-172 aa and 245-321 aa in green; iii) distal lobe (DL) formed by 173-244 aa in blue; 
and v) stem domain (SD) formed by 353-402 aa in white. b,c) Ribbon representations of 
a homology model of a2N1-352. Structural domains are colored as above. It should be 
noted that stem domain is not present in this model. b) Bottom view from the membrane 
towards V1-sector. c) Top view from the V1-sector towards the membrane. This view is 
rotated by 180° vertically relative to the view in b. 
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Figure 3. Synthesis and NMR analysis of peptides overlapping and 
corresponding to stem domain of a2N1-402. a) The C-terminal amino acid sequence of 
a2N1-402. The end of proximal lobe (PL) domain (332-353 aa) is shown in peach and stem 
domain (SD) is in white. Overlapping synthetic peptides a2N339-395 and a2N386-402 are 
shown in cyan. The C-terminal part of a2N339-395 peptide (called a2N368-395), for which 
structure was solved by NMR spectroscopy is shown in grey. b) Table of structural 
statistics for the amino acids of a2N368-395 and a2N386-402 peptides determined by NMR 
analysis in solution. 
 
Figure 4. NMR data and analysis of a2N339-395 and a2N386-402 peptides. 
Assignment of cross-peaks in the NOESY spectrum of a) a2N339-395 and b) a2N386-402 
Peak picking was done in Sparky 3.1 software and peaks were identified based on 
TOCSY spectrum. Since the 2D NOESY assignment of a2N339-395 reveals an unstructured 
N-terminal part, the calculation was performed only for the C-terminal region with the 
residues 368 to 395, called a2N368-395. The amino acid sequence of c) a2N368-395 and d) 
a2N386-402 peptides and their secondary structure elements based on 1Hα chemical shifts 
with respect to the random coil values. NOESY connectivity plot of peptides e) a2N368-395 
and f) a2N386-402 are indicative of the residues connected in space revealing the presence 
of a helical structure. 
 
Figure 5. NMR structure of a2N368-395 peptide. a) NMR structure of the peptide 
a2N368-395 showing superimposition of 20 structures calculated by Cyana 3.1 package and 
revealing a partially α-helical formation. b) Cartoon representation of a single NMR 
structure of a2N368-395. c, d) The molecular surface electrostatic potential of peptide c) 
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a2N368-395 and d) its 180 view respectively generated by Pymol (DeLano, 2002). The 
positive potentials are drawn in blue, negative in red and hydrophobic in light grey. 
 
Figure 6. NMR structure of a2N386-402 peptide. a) NMR structure of the peptide 
a2N386-402 showing superimposition of 20 structures calculated by Cyana 3.1 package and 
revealing a partially α-helical formation. b) Cartoon representation of a single NMR 
structure of a2N386-402. c, d) The molecular surface electrostatic potential of peptide c) 
a2N386-402 and d) its 180 view respectively generated by Pymol (DeLano, 2002). The 
positive potentials are drawn in blue, negative in red and hydrophobic in light grey. 
 
Figure 7. Structural model of complete a2N1-402 and identification of CTH2 
and G/E-peripheral stalks binding sites. a-d) Structural molecular model of a2N1-402 
and identification of two distinct CTH2 binding sites. a) Ribbon representation of a top 
view of a molecular model of a2N1-402 showing six cytohesin-2 binding peptides as 
follows: i) a2N1-17 (in red); ii) a2N35-49 (in purple); iii) a2N198-214 (in blue); iv) a2N215-230 
(in cyan); v) a2N313-331 (in yellow) and vi) a2N386-402 (in orange). Note, that α-helix XIII 
of appendage region a2N353-402 (lower left part with peptide a2N386-402) lays close to α-
helix I of core region a2N1-352. b) View of proximal lobe (PL) and details of the first 
cytohesin-2 binding site formed by a2N1-17, a2N35-49, a2N313-331 and a2N386-402 peptides. 
Note that three peptides a2N1-17, a2N35-49 and a2N313-331 form a continuous surface while 
a2N386-402 peptide is separate. This view is rotated by 90° vertically and then counter-
clockwise by 90° horizontally relatively to the view in a. c) View of distal lobe (DL) and 
details of the second CTH2 binding site formed by a2N198-214 and a2N215-230 peptides. 
This view is rotated clockwise 90° horizontally relatively to the view in a. d) Ribbon 
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representation of a top view of a molecular model of a2N1-402. A ll six CYH2 binding 
peptides are colored in red, while five amino acids G170, T255, P336, R340 and N358 
identified in G/E-stalks binding vicinity are colored in blue (Qi & Forgac, 2008). Amino 
acids P336, R340 and N358 forming first G/E-stalk binding site in PL are on the left, while 
amino acids G170 and T255 forming second G/E-stalk binding site in DL are on the right.  
 
Figure 8. Identification of V-ATPase interface involved in binding and 
signaling with CTH2. a) Two V-ATPase derived peptides a2N1-17 and a2N35-49 are 
forming a specific interaction interface on proximal lobe sub-domain of a2N (shown by 
gray rectangle) that is involved in interaction with Sec7 domain of CTH2. b,c) 
Experimental testing of our model demonstrated a potent inhibition of Sec7/Arf1-GEF 
activity by both b) Bio-a2N1-17 -TAT (IC50 = 1.5 µM) and c) Bio-a2N35-49 -TAT (IC50 = 
0.9 µM) interface forming peptides. d,e,f) The V-ATPase-derived peptides: d) Bio-a2N18-
34 -TAT; e) Bio-a2N75-91-TAT and f) Bio-a2N313-331-TAT that are  not involved in the 
formation of binding-competent interface, are unable inhibit enzymatic GEF activity of 
Sec7 domain. g) Sequences of V-ATPase-derived synthetic peptides tested in enzymatic 
GEF-activity assay of CTH2 Sec7 domain.  
 
Figure 9. Model of interactions between CTH2 and V-ATPase: Implication 
for cross-talk and regulation of CTH2 and V-ATPase functions.  a-b) The 3D 
reconstruction EM map of the related A-ATP synthase of the archaeon P. furiosus 
enzyme. The presented molecular model of a2N1-402 (yellow), the c-ring (wheat) and G/E-
peripheral stalks (G, cyan and E, green/red) were used for the fitting. Cytohesin-2 
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(CTH2) (green) has been accommodated based on the interactions described in the 
Figures 7a-c. a) This model proposes that binding of CTH2 to the V-ATPase may 
destabilize the binding of both G/E peripheral stalks to a-subunit, which could promote 
the disassembly of the V1- and VO-sectors and inactivation of H+-pumping of the V-
ATPase. b) This model proposes that ion-translocation in the interface of the c-ring and 
the C-terminal membrane-embedded domain of a-subunit (yellow cylinder), could be 
affected by the binding of the CTH2 to the proximal lobe of N-terminal domain of 2-
subunit of V-ATPase. 
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